Status:
COMPLETED
Blood Pressure and Obstructive Sleep Apnea
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
The Effects of Obstructive Sleep Apnea on Blood Pressure Measurement
Eligibility:
All Genders
18+ years
Brief Summary
Bidirectional and causal relationship exists between obstructive sleep apnea (OSA) and hypertension in a dose-response manner, independent of confounding variables such as age, smoking, and body mass ...
Detailed Description
Approximately 50% of patients with obstructive sleep apnea (OSA) have hypertension; up to 30% of patients with hypertension have OSA, and the prevalence is even higher in those of resistant hypertensi...
Eligibility Criteria
Inclusion
- (1). Individuals who underwent full-night polysomnography at Taipei VGH for symptoms related to obstructive sleep apnea, such as snoring and daytime somnolence; (2). Feasibility to measure BP via wrist monitors; (3). Confirmation of wakefulness through electroencephalography.
Exclusion
- (1). Failure to measure BP via wrist monitors; (2). Age younger than 18 years; (3). Sleep efficiency less than 50%; (4). Central sleep apnea ≥ 50%
Key Trial Info
Start Date :
October 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 16 2023
Estimated Enrollment :
2037 Patients enrolled
Trial Details
Trial ID
NCT06027424
Start Date
October 26 2022
End Date
July 16 2023
Last Update
September 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, Taiwan